OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Predicting and preventing heart failure in type 2 diabetes
Ambarish Pandey, Muhammad Shahzeb Khan, Kershaw V. Patel, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 8, pp. 607-624
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study
Lovedeep Singh Dhingra, Arya Aminorroaya, Veer Sangha, et al.
European Heart Journal (2025)
Closed Access | Times Cited: 2

Hypertension Related Co-Morbidities and Complications in Women of Sub-Saharan Africa: A Brief Review
Taija Hahka, Rebecca Slotkowski, Anum Akbar, et al.
Circulation Research (2024) Vol. 134, Iss. 4, pp. 459-473
Closed Access | Times Cited: 5

Scalable Risk Stratification for Heart Failure Using Artificial Intelligence applied to 12-lead Electrocardiographic Images: A Multinational Study
Lovedeep Singh Dhingra, Arya Aminorroaya, Veer Sangha, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4

Anthocyanins and Type 2 Diabetes: An Update of Human Study and Clinical Trial
Aleksandra Kozłowska, Aneta Nitsch‐Osuch
Nutrients (2024) Vol. 16, Iss. 11, pp. 1674-1674
Open Access | Times Cited: 4

Exploring aldose reductase inhibitors as promising therapeutic targets for diabetes-linked disabilities
Saheem Ahmad, Mohammad Faizan Ali Ahmad, Saif Khan, et al.
International Journal of Biological Macromolecules (2024) Vol. 280, pp. 135761-135761
Closed Access | Times Cited: 4

A Case-Control Study on Risk Factors and Outcomes in Congestive Heart Failure
Mohammad Shakil Ahmad, Abdulrahman Obaid Matar Alharbi, Abdullah Tawakul, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access

Stress hyperglycemia ratio and the clinical outcome of patients with heart failure: a meta-analysis
Liang Li, Zhikun Zhao, Shasha Wang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3

Real-life underuse of SGLT2 inhibitors for patients with type 2 diabetes at high cardiorenal risk
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 13, pp. 100184-100184
Open Access | Times Cited: 9

Association of diabetes‐specific heart failure risk score with presence of subclinical cardiomyopathy among individuals with diabetes: A prospective study
Zainali Chunawala, Neil Keshvani, Matthew W. Segar, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 3, pp. 699-701
Closed Access | Times Cited: 2

Nitro-fatty acids: mechanisms of action, roles in metabolic diseases, and therapeutics
Hui Ni, Xin Tan, Jie Du, et al.
Current Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 2

Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study
Kershaw V. Patel, Zainali Chunawala, Subodh Verma, et al.
Journal of the American College of Cardiology (2024)
Closed Access | Times Cited: 2

Impact of telemedical management on hospitalization and mortality in heart failure patients with diabetes: a post-hoc subgroup analysis of the TIM-HF2 trial
Friedrich Koehler, Johanna Koehler, Peter Bramlage, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status
Muhammad Shahzeb Khan, Javed Butler, Rebecca Young, et al.
JACC Heart Failure (2024) Vol. 12, Iss. 10, pp. 1750-1759
Closed Access | Times Cited: 1

Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort—the DIABET-IC study
Rafael González Manzanares, María Anguita-Gámez, Javier Muñiz, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Artificial Intelligence to Diagnose Complications of Diabetes
Alessandra T. Ayers, Cindy Ho, David Kerr, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 1

Prevalence and Predictors of Subclinical Cardiomyopathy in Patients With Type 2 Diabetes in a Health System
Aditya Nagori, Matthew W. Segar, Neil Keshvani, et al.
Journal of Diabetes Science and Technology (2023)
Closed Access | Times Cited: 3

Comorbidities in heart diseases—Extent and sequelae
Ingolf Cascorbi
Deleted Journal (2024) Vol. 18, Iss. 2, pp. 151-155
Closed Access

Efficacy and safety of bimekizumab in the treatment of psoriatic arthritis: a systematic review and meta-analysis
Q. Y. Su, Yang Liu, Ting-Yu Cao, et al.
Expert Opinion on Drug Safety (2024), pp. 1-9
Closed Access

Using Artificial Intelligence to Predict Heart Failure Risk from Single-lead Electrocardiographic Signals: A Multinational Assessment
Lovedeep Singh Dhingra, Arya Aminorroaya, Aline Pedroso Camargos, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Influencia de la presencia y tipo de enfermedad cardiovascular sobre el riesgo de mortalidad de los pacientes con diabetes tipo 2: estudio DIABET-IC
José Antonio Gimeno Orna, Ana Belén Mañas Martínez, Luis Rodrı́guez Padial, et al.
Endocrinología Diabetes y Nutrición (2024) Vol. 71, Iss. 7, pp. 278-289
Closed Access

Page 1 - Next Page

Scroll to top